ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,646, issued on July 15, was assigned to Kite Pharma Inc. (Santa Monica, Calif.).
"Chimeric antigen receptor T cell therapy" was invented by Rhine Shen Garcia (Santa Monica, Calif.) and Vicki Plaks (Santa Monica, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides methods of treating a malignancy comprising administering an effective dose of an immune cell therapy (e.g., a chimeric antigen receptor genetically modified T cell immunotherapy) and methods for manufacturing such immunotherapy. Some aspects of the disclosure relate to methods of determining objective response of a patient to an immune cell immunotherapy based on ...